Katherine A Ornstein1, Melissa D Aldridge2, Melissa M Garrido3, Rebecca Gorges2, Diane E Meier2, Amy S Kelley3. 1. Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York2Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, New York. 2. Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York. 3. Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York3Geriatrics Research, Education, and Clinical Center, James J. Peters Veterans Affairs Medical Center, Bronx, New York.
Abstract
IMPORTANCE: Family caregivers of individuals with serious illness are at risk for depressive symptoms and depression. Hospice includes the provision of support services for family caregivers, yet evidence is limited regarding the effect of hospice use on depressive symptoms among surviving caregivers. OBJECTIVE: To determine the association between hospice use and depressive symptoms in surviving spouses. DESIGN, SETTING, AND PARTICIPANTS: We linked data from the Health and Retirement Study, a nationally representative longitudinal survey of community-dwelling US adults 50 years or older, to Medicare claims. Participants included a propensity score-matched sample of 1016 Health and Retirement Study decedents with at least 1 serious illness and their surviving spouses interviewed between August 2002 and May 2011. We compared the spouses of individuals enrolled in hospice with the spouses of individuals who did not use hospice, performing our analysis between January 30, 2014, and January 16, 2015. EXPOSURES: Hospice enrollment for at least 3 days in the year before death. MAIN OUTCOMES AND MEASURES: Spousal depressive symptom scores measured 0 to 2 years after death with the Center for Epidemiologic Studies Depression Scale, which is scored from 0 (no symptoms) to 8 (severe symptoms). RESULTS: Of the 1016 decedents in the matched sample, 305 patients (30.0%) used hospice services for 3 or more days in the year before death. Of the 1016 spouses, 51.9% had more depressive symptoms over time (mean [SD] change, 2.56 [1.65]), with no significant difference related to hospice use. A minority (28.2%) of spouses of hospice users had improved Center for Epidemiologic Studies Depression Scale scores compared with 21.7% of spouses of decedents who did not use hospice, although the difference was not statistically significant (P = .06). Among the 662 spouses who were the primary caregivers, 27.3% of spouses of hospice users had improved Center for Epidemiologic Studies Depression Scale scores compared with 20.7% of spouses of decedents who did not use hospice; the difference was not statistically significant (P = .10). In multivariate analysis, the odds ratio for the association of hospice enrollment with improved depressive symptoms after the spouse's death was 1.63 (95% CI, 1.00-2.65). CONCLUSIONS AND RELEVANCE: After bereavement, depression symptoms increased overall for surviving spouses regardless of hospice use. A modest reduction in depressive symptoms was more likely among spouses of hospice users than among spouses of nonhospice users.
IMPORTANCE: Family caregivers of individuals with serious illness are at risk for depressive symptoms and depression. Hospice includes the provision of support services for family caregivers, yet evidence is limited regarding the effect of hospice use on depressive symptoms among surviving caregivers. OBJECTIVE: To determine the association between hospice use and depressive symptoms in surviving spouses. DESIGN, SETTING, AND PARTICIPANTS: We linked data from the Health and Retirement Study, a nationally representative longitudinal survey of community-dwelling US adults 50 years or older, to Medicare claims. Participants included a propensity score-matched sample of 1016 Health and Retirement Study decedents with at least 1 serious illness and their surviving spouses interviewed between August 2002 and May 2011. We compared the spouses of individuals enrolled in hospice with the spouses of individuals who did not use hospice, performing our analysis between January 30, 2014, and January 16, 2015. EXPOSURES: Hospice enrollment for at least 3 days in the year before death. MAIN OUTCOMES AND MEASURES: Spousal depressive symptom scores measured 0 to 2 years after death with the Center for Epidemiologic Studies Depression Scale, which is scored from 0 (no symptoms) to 8 (severe symptoms). RESULTS: Of the 1016 decedents in the matched sample, 305 patients (30.0%) used hospice services for 3 or more days in the year before death. Of the 1016 spouses, 51.9% had more depressive symptoms over time (mean [SD] change, 2.56 [1.65]), with no significant difference related to hospice use. A minority (28.2%) of spouses of hospice users had improved Center for Epidemiologic Studies Depression Scale scores compared with 21.7% of spouses of decedents who did not use hospice, although the difference was not statistically significant (P = .06). Among the 662 spouses who were the primary caregivers, 27.3% of spouses of hospice users had improved Center for Epidemiologic Studies Depression Scale scores compared with 20.7% of spouses of decedents who did not use hospice; the difference was not statistically significant (P = .10). In multivariate analysis, the odds ratio for the association of hospice enrollment with improved depressive symptoms after the spouse's death was 1.63 (95% CI, 1.00-2.65). CONCLUSIONS AND RELEVANCE: After bereavement, depression symptoms increased overall for surviving spouses regardless of hospice use. A modest reduction in depressive symptoms was more likely among spouses of hospice users than among spouses of nonhospice users.
Authors: Ipsit V Vahia; Thomas W Meeks; Wesley K Thompson; Colin A Depp; Sidney Zisook; Matthew Allison; Lewis L Judd; Dilip V Jeste Journal: Am J Geriatr Psychiatry Date: 2010-03 Impact factor: 4.105
Authors: Elizabeth H Bradley; Holly Prigerson; Melissa D A Carlson; Emily Cherlin; R Johnson-Hurzeler; Stanislav V Kasl Journal: Am J Psychiatry Date: 2004-12 Impact factor: 18.112
Authors: Melissa D A Carlson; Jeph Herrin; Qingling Du; Andrew J Epstein; Colleen L Barry; R Sean Morrison; Anthony L Back; Elizabeth H Bradley Journal: J Clin Oncol Date: 2010-08-30 Impact factor: 44.544
Authors: Lucinda Lee Roff; Louis D Burgio; Laura Gitlin; Linda Nichols; William Chaplin; J Michael Hardin Journal: J Gerontol B Psychol Sci Soc Sci Date: 2004-07 Impact factor: 4.077
Authors: Paul R Duberstein; Paul K Maciejewski; Ronald M Epstein; Joshua J Fenton; Benjamin Chapman; Sally A Norton; Michael Hoerger; Marsha N Wittink; Daniel J Tancredi; Guibo Xing; Supriya Mohile; Richard L Kravitz; Holly G Prigerson Journal: J Palliat Med Date: 2019-06-25 Impact factor: 2.947
Authors: Katherine A Ornstein; Jennifer L Wolff; Evan Bollens-Lund; Omari-Khalid Rahman; Amy S Kelley Journal: Health Aff (Millwood) Date: 2019-06 Impact factor: 6.301
Authors: Maija Reblin; Brian R W Baucom; Margaret F Clayton; Rebecca Utz; Michael Caserta; Dale Lund; Kathi Mooney; Lee Ellington Journal: Psychooncology Date: 2019-04-05 Impact factor: 3.894
Authors: Claire K Ankuda; Donovan T Maust; Mohammed U Kabeto; Ryan J McCammon; Kenneth M Langa; Deborah A Levine Journal: J Am Geriatr Soc Date: 2017-08-24 Impact factor: 5.562
Authors: Katherine A Ornstein; Melissa M Garrido; Albert L Siu; Evan Bollens-Lund; Kenneth M Langa; Amy S Kelley Journal: Health Serv Res Date: 2018-02-28 Impact factor: 3.402
Authors: Katherine A Ornstein; Melissa D Aldridge; Melissa M Garrido; Rebecca Gorges; Evan Bollens-Lund; Albert L Siu; Kenneth M Langa; Amy S Kelley Journal: J Pain Symptom Manage Date: 2016-11-15 Impact factor: 3.612
Authors: Pallavi Kumar; Alexi A Wright; Laura A Hatfield; Jennifer S Temel; Nancy L Keating Journal: J Clin Oncol Date: 2016-12-19 Impact factor: 44.544
Authors: Katherine A Ornstein; Melissa D Aldridge; Christine A Mair; Rebecca Gorges; Albert L Siu; Amy S Kelley Journal: J Palliat Med Date: 2016-03-18 Impact factor: 2.947